IMVT compared with TNGX: revenue, margins and what each company keeps, and the suppliers and customers both name

IMVTImmunovant, Inc.

Mkt capRevenueRevenue

TNGXTango Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

IMVTImmunovant, Inc.

TNGXTango Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IMVT 4

ROIVRoivant Sciencessupplier

—Ypsomedunlistedsupplier

—Roivant Sciences GmbHunlistedsupplier

—HanAllunlistedsupplier

Shared 0

No shared counterparties.

Only TNGX 1

—WuXi AppTecunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

IMVTImmunovant, Inc.

28.78▼−1.33%

Mkt cap$6.0BRevenue—Revenue—

TNGXTango Therapeutics, Inc.

22.17▼−2.40%

Regular sessionNov 2 '26

Mkt cap$3.8BRevenue$54MQ3 FY25Revenue$42MFY24

Compare

Regular sessionNov 2 '26

IMVTImmunovant, Inc.

TNGXTango Therapeutics, Inc.

28.78▼−1.33%

Price

22.17▼−2.40%

$6.0B

Mkt cap

$3.8B

—

Revenue

$54MQ3 FY25

—

Revenue

$42MFY24

IMVT28.78▼−1.33%vsTNGX22.17▼−2.40%Regular sessionNov 2 '26